U.S Physical Therapy Revenue 2012-2026 | USPH

U.S Physical Therapy revenue from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
U.S Physical Therapy Annual Revenue
(Millions of US $)
2025 $781
2024 $671
2023 $605
2022 $553
2021 $495
2020 $423
2019 $482
2018 $454
2017 $414
2016 $357
2015 $331
2014 $305
2013 $264
2012 $250
2011 $232
U.S Physical Therapy Quarterly Revenue
(Millions of US $)
2026-03-31 $198
2025-12-31 $203
2025-09-30 $197
2025-06-30 $197
2025-03-31 $184
2024-12-31 $180
2024-09-30 $168
2024-06-30 $167
2024-03-31 $156
2023-12-31 $155
2023-09-30 $150
2023-06-30 $151
2023-03-31 $149
2022-12-31 $141
2022-09-30 $140
2022-06-30 $141
2022-03-31 $132
2021-12-31 $130
2021-09-30 $126
2021-06-30 $127
2021-03-31 $112
2020-12-31 $117
2020-09-30 $109
2020-06-30 $84
2020-03-31 $113
2019-12-31 $122
2019-09-30 $117
2019-06-30 $126
2019-03-31 $116
2018-12-31 $117
2018-09-30 $113
2018-06-30 $115
2018-03-31 $108
2017-12-31 $109
2017-09-30 $103
2017-06-30 $104
2017-03-31 $98
2016-12-31 $91
2016-09-30 $88
2016-06-30 $90
2016-03-31 $87
2015-12-31 $87
2015-09-30 $84
2015-06-30 $83
2015-03-31 $77
2014-12-31 $79
2014-09-30 $78
2014-06-30 $78
2014-03-31 $70
2013-12-31 $69
2013-09-30 $66
2013-06-30 $67
2013-03-31 $63
2012-12-31 $61
2012-09-30 $62
2012-06-30 $64
2012-03-31 $63
2011-12-31 $55
2011-09-30 $60
2011-06-30 $60
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.157B $0.781B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $29.514B 13.37
Quest Diagnostics (DGX) United States $21.197B 19.44
Elanco Animal Health (ELAN) United States $11.500B 24.35
Encompass Health (EHC) United States $10.662B 19.64
DaVita (DVA) United States $10.023B 13.82
Chemed (CHE) United States $5.639B 19.57
Option Care Health (OPCH) United States $4.553B 18.71
RadNet (RDNT) United States $4.302B 142.13
LifeStance Health (LFST) United States $2.495B 320.00
Addus HomeCare (ADUS) United States $1.719B 16.61
Astrana Health (ASTH) United States $1.536B 31.40
Aveanna Healthcare Holdings (AVAH) United States $1.353B 12.20
Pennant (PNTG) United States $1.072B 31.31
Daxor (DXR) United States $0.048B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.032B 0.00
Psychemedics (PMD) United States $0.000B 0.00